Cargando…
PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
Autores principales: | Leathers, James S, Balderramo, Domingo, Prieto, Jhon, Diehl, Fernando, Gonzalez-Ballerga, Esteban, Ferreiro, Melina R., Carrera, Enrique, Barreyro, Fernando, Diaz-Ferrer, Javier, Singh, Dupinder, Mattos, Angelo Z., Carrilho, Flair, Debes, Jose D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243140/ https://www.ncbi.nlm.nih.gov/pubmed/30467514 http://dx.doi.org/10.5812/hepatmon.82345 |
Ejemplares similares
-
MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort
por: Goble, Spencer, et al.
Publicado: (2023) -
Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans
por: Ayoub, Alan, et al.
Publicado: (2023) -
Icteric Variant of Stauffer Syndrome as a Paraneoplastic Manifestation of Type 1 Papillary Renal Cell Carcinoma
por: Sorda, Juan Antonio, et al.
Publicado: (2023) -
Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America
por: Balderramo, Domingo, et al.
Publicado: (2021) -
Current impact of viral hepatitis on liver cancer development: The challenge remains
por: de Mattos, Ângelo Zambam, et al.
Publicado: (2021)